Allergan plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2018
January 29, 2019 at 05:30 pm IST
Allergan plc announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced sales was USD 4,079.7 million compared to USD 4,326.1 million a year ago. Operating loss was USD 5,384.1 million compared to USD 90.5 million a year ago. Net loss was USD 4,299.9 million compared to net income of USD 3,121.3 million a year ago. Basic loss per share from continuing operations was USD 12.83 compared to basic earnings per share from continuing operations of USD 10.37 a year ago. Basic loss per share was USD 12.83 compared to basic earnings per share of USD 9.21 a year ago. Diluted loss per share from continuing operations was USD 12.83 compared to diluted earnings per share from continuing operations of USD 9.97 a year ago. Diluted loss per share was USD 12.83 compared to diluted earnings per share of USD 8.88 a year ago. For the full year, sales was USD 15,787.4 million compared to USD 15,940.7 million a year ago. Operating loss was USD 6,247.6 million compared to USD 5,921.2 million a year ago. Net loss was USD 5,096.4 million compared to USD 4,125.5 million a year ago. Basic loss per share from continuing operations was USD 15.26 compared to USD 11.99 a year ago. Basic loss per share was USD 15.26 compared to USD 13.19 a year ago.